Open an account

Anbio Biotechnology

NNNN · NASDAQ

$3.73+$0.46 (+14.07%)TodayMarket closed ·
Prev close $3.27

About NNNN

Anbio Biotechnology is a medical device company. The company is headquartered in Frankfurt, Hessen and currently employs 27 full-time employees. The company went IPO on 2025-02-19. The firm is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Employees
27
Headquarters
Frankfurt, Hessen
Listed
Feb 19, 2025
Sector
Health Care
Industry
Biotechnology
Website
anbiobiotechnology.com

NNNN key statistics

Market cap
536.71M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
98.45K
Volume
194.43K
Open price
$3.43
High today
$4.24
Low today
$3.42
52 Week high
$44.73
52 Week low
$3.09

Anbio Biotechnology (NNNN) at a glance

As of Oct 20, 2026, Anbio Biotechnology (NNNN) shares are priced at $3.73, giving the company a market cap of 536.71M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.42 and $4.24. The current price is 9.2% above the day's low and 12.0% below its high.

Volume so far is 194.43K shares, above the average of 98.45K shares a day.

Over the past year Anbio Biotechnology has ranged from $3.09 to $44.73, and now sits 2% of the way up that range.

NNNN news

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • Press releaseGlobe Newswire

    Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Avi Kapoor

    Dow Jumps Over 200 Points; ISM Services PMI Falls In September

  • Press releaseGlobe Newswire

    Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releaseGlobe Newswire

    Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions

Similar companies

Companies in the same industry as Anbio Biotechnology

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.